Skip to main content
Veterinary Medicines

Calfoset injekcinis tirpalas arkliams, galvijams, kiaulėms, avims ir ožkoms

Authorised
  • Magnesium chloride hexahydrate
  • CALCIUM GLYCEROPHOSPHATE
  • Calcium gluconate

Product identification

Medicine name:
Calfoset injekcinis tirpalas arkliams, galvijams, kiaulėms, avims ir ožkoms
Active substance:
  • Magnesium chloride hexahydrate
  • CALCIUM GLYCEROPHOSPHATE
  • Calcium gluconate
Target species:
  • Horse
  • Cattle
  • Pig
  • Sheep
  • Goat
  • Pig (piglet)
Route of administration:
  • Intravenous use
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Magnesium chloride hexahydrate
    4.18
    gram(s)
    /
    100.00
    millilitre(s)
  • CALCIUM GLYCEROPHOSPHATE
    8.13
    gram(s)
    /
    100.00
    millilitre(s)
  • Calcium gluconate
    32.82
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
    • Cattle
    • Pig
    • Sheep
    • Goat
  • Intramuscular use
    • Cattle
    • Pig
    • Pig (piglet)
    • Sheep
    • Goat
  • Subcutaneous use
    • Cattle
    • Pig
    • Pig (piglet)
    • Sheep
    • Goat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/11/2025/001-002
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 3/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."